Nuvalent (NUVL) Retained Earnings (2020 - 2026)
Nuvalent (NUVL) posted Retained Earnings of -$1.4 million for Q1 2026, up 99.86% on a QoQ basis from -$972.4 million in Q4 2025, and up 99.79% year-over-year from -$678227.5 in Q1 2025.
Nuvalent (NUVL) Retained Earnings (2020 - 2026) Analysis & Trends
Nuvalent's Retained Earnings history runs 7 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- Quarterly Retained Earnings rose 99.79% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 99.79% YoY) and the FY2025 annual result came in at -$972.4 million, down 77.76% from the prior year.
- Retained Earnings was -$1.4 million for Q1 2026 at Nuvalent, up from -$972.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.4 million in Q2 2025 and bottomed at -$972.4 million in Q4 2025.
- A 5-year average of -$287.4 million and a median of -$214.4 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings tumbled 57854.66% — and 2025, when it soared 100.35%.
- Nuvalent's Retained Earnings stood at -$494000.0 in 2022, then tumbled by 57854.66% to -$286.3 million in 2023, then tumbled by 91.08% to -$547.1 million in 2024, then plunged by 77.76% to -$972.4 million in 2025, then surged by 99.86% to -$1.4 million in 2026.
- Business Quant data shows NUVL's Retained Earnings at -$1.4 million in Q1 2026, -$972.4 million in Q4 2025, and -$853.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -1.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.36 Mn |
| Dec 31, 2025 | -972.43 Mn |
| Sep 30, 2025 | -853.72 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | -631.60 Mn |
| Dec 31, 2024 | -547.05 Mn |
| Sep 30, 2024 | -472.29 Mn |
| Jun 30, 2024 | -387.94 Mn |
| Mar 31, 2024 | -330.78 Mn |
| Dec 31, 2023 | -286.30 Mn |
| Sep 30, 2023 | -1.31 Mn |
| Jun 30, 2023 | -214.36 Mn |
| Mar 31, 2023 | -185.27 Mn |
| Dec 31, 2022 | -494,000.00 |
| Sep 30, 2022 | -866,000.00 |
| Jun 30, 2022 | -1.13 Mn |
| Mar 31, 2022 | -1.02 Mn |
| Dec 31, 2021 | -228,000.00 |
| Sep 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -48.51 Mn |